If your holidays will include elderly visitors, it may be important to do some advance planning to help ensure their safety. Dr. Sonja Rosen, chief of Geriatric Medicine at Cedars-Sinai, offers tips to prevent falls and keep older guests comfortable.
Families and caregivers of people with cancer may view the holidays as a particularly challenging time, often feeling as though they have to live up to the ideal of merry and bright, when they—and those they’re tending—typically don’t feel that way. Cedars-Sinai experts offer 6 tips for making the most of the holidays while caring for someone with cancer.
New 12-month data from the Smidt Heart Institute at Cedars-Sinai backs up an earlier study proving that a pharmacist-led, barbershop-based medical intervention can successfully lower blood pressure in high-risk African-American men. The follow-up research was published Dec. 17, 2018, in the journal Circulation.
Here's a great holiday story about a 20-year-old Reno, NV, man whose mother saved his life. Harley Brackney's snowboarding accident and subsequent trip to the emergency room led to the shocking discovery that he had a life-altering condition - stage 5 renal failure - and needed a kidney transplant. Fortunately for Harley Brackney, his mom was a perfect match and instead of waiting 7 to 10 years for a donor organ -- as many people must -- he was able to have a transplant in just a matter of months.
Of the 165,000 men in the U.S. expected to be diagnosed with prostate cancer this year, about half will have low-risk disease. Many of those patients will opt for active surveillance -- a process in which men with low-risk, slow-growing prostate cancer are regularly monitored to see if the cancer starts to grow and requires treatment.
Vascular surgeon Ali Azizzadeh, MD, was the first to use a newly approved, minimally invasive device to perform a series of innovative surgeries on patients with aneurysms of the aorta, the main vessel that delivers blood from the heart to the rest of the body.
New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.
For the first time, a 360-degree virtual reality (VR) Continuing Medical Education (CME) accredited course in GI surgery is available for streaming to surgeons and medical professionals. The course is a collaboration between medical experts at Cedars-Sinai and GIBLIB, the streaming media platform offering the largest library of on-demand medical lectures and surgical videos in the newest formats.
Usually one would have to visit an art museum in order to see the beautiful landscapes by Vietnamese-American artist, Christine Nguyen, but drivers in West Hollywood get an up-close view of her oversized artwork as part of their daily commute. Nguyen's art is displayed on protective fencing surrounding construction at the future home of the Cedars-Sinai Saul & Joyce Brandman Breast Center.
A new study has identified a novel molecular driver of lethal prostate cancer, along with a molecule that could be used to attack it. The findings were made in laboratory mice. If confirmed in humans, they could lead to more effective ways to control certain aggressive types of prostate cancer, the second-leading cause of cancer death for men in the U.S.
Heitham Hassoun, MD, a leading international health expert, has been named vice president and medical director of Cedars-Sinai's Center for International Health. Hassoun joins Cedars-Sinai from Johns Hopkins Medicine, where he was medical director for Global Healthcare at Johns Hopkins Medicine International.
According to a recently released national report the Cedars-Sinai Comprehensive Transplant Center's Liver Transplant Program had the best one-year survival outcome of all hospitals in California, with 96 percent of patients surviving beyond the one-year milestone. Kidney transplant and heart transplant patients also had excellent outcomes, with 97 percent of patients surviving past the one-year benchmark.
New findings about sudden cardiac arrest, one of medicine's biggest mysteries, were revealed at the American Heart Association Scientific Sessions.
Researchers at the Smidt Heart Institute at Cedars-Sinai discovered that a non-treatable form of lethal heart rhythm responsible for sudden cardiac arrest is twice as likely to be found in patients with the most common form of heart failure—heart failure with preserved ejection fraction (HFpEF), compared to heart failure with reduced ejection fraction (HFrEF).
Cholene Espinoza, MD, is the second woman to fly a U-2 spy plane, and while her experience “touching the stars” was breathtaking, it doesn’t compare to the magic of her richest role yet: welcoming babies to the world.
The end of daylight saving time—on Nov.4 this year—could create a more dangerous evening commute for people on foot, as darkness falls earlier and drivers find it harder to see on the road, says a Cedars-Sinai trauma physician.
A team led by a Cedars-Sinai physician-scientist has discovered a biomarker—a protein found in the blood—for the most common type of heart failure, a new study published today in JAMA Cardiology shows.
As women scramble to keep up with work, family and the scores of chores they tackle, it’s easy for breast care to fall by the wayside. In recognition of Breast Cancer Awareness Month, Cedars-Sinai breast surgical oncologist Nimmi Kapoor, MD, breast medical oncologist Reva Basho, MD, and three breast cancer survivors offer advice—from mammograms to immunotherapy and breast reconstruction—to keep women in the know
A new method developed at Cedars-Sinai may revolutionize how severe injuries are treated by harnessing stem cells to regrow tissue damaged by major trauma, such as traffic accidents or war injuries.
A surgical technique called EDAS (encephaloduroarteriosynangiosis) significantly decreases the rate of stroke recurrence and death for patients with severe atherosclerosis of the brain arteries, according to findings of a Phase IIa clinical trial to be presented Oct. 18 at the World Stroke Congress in Montreal.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right